FL2-10020-17448
4 vaccinations
8 coded responses
26 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 956 / CA
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- N/A
Timeline
-
2021-03-18
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Registered in v-safe
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-24
- 2021-03-25
-
2021-04-01
Survey response — day 14, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Pain at injection site again. Low grade and tolerable, but it has gone away after the first 3 days and returned.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Dose 2 — Pfizer-BioNTech
- 2021-04-15
- 2021-04-16
- 2021-04-19
-
2021-04-24
Survey response — day 14, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Still very faint pain at injection site 2 weeks after 2nd dose, but otherwise fine and dont regret it!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Survey response — day 21, dose 2MedDRA: Injection site pain, Injection site swelling — Feeling: GoodFree text: Still lingering slight injection site pain and minor swelling, but not bad. Still thankful I got my shots!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-22
-
2021-07-13
Survey response — 3 months, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Mild/Ongoing injection site painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-11
-
2021-12-17
Dose 3 — Pfizer-BioNTech
-
2022-04-21
Dose 4 — Pfizer-BioNTech
-
2022-04-21
Survey response — day 0, dose 4MedDRA: Dysgeusia — Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tirednessFree text: Weird taste back of tongue/throatMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Survey response — days 1–6 daily, dose 4MedDRA: Dysgeusia — Feeling: Good · Site: Pain, Redness, Swelling · Headache, Joint painsFree text: Weird taste in back of mouthMedDRA releases: 2024-11 · check-in free text available
- 2022-04-24
- 2022-04-25
- 2022-04-27
- 2022-04-28
- 2022-05-05
-
2022-05-12
Survey response — day 21, dose 4MedDRA: Injection site pain, Injection site swelling — Feeling: GoodFree text: Slight/minor lingering pain and swelling at injection site.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-27
-
2022-06-02
Survey response — day 42, dose 4MedDRA: Injection site pain — Feeling: GoodFree text: Very minor inspection site painMedDRA releases: 2024-11 · check-in free text available
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-10 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
| 4 | 2022-04-21 | Pfizer-BioNTech | No |
Free text
Release 6 — day 14, dose 1
Symptoms: Pain at injection site again. Low grade and tolerable, but it has gone away after the first 3 days and returned.
Release 7 — day 14, dose 2
Symptoms: Still very faint pain at injection site 2 weeks after 2nd dose, but otherwise fine and dont regret it!
Release 8 — day 21, dose 2
Symptoms: Still lingering slight injection site pain and minor swelling, but not bad. Still thankful I got my shots!
Release 9 — 3 months, dose 2
Symptoms: Mild/Ongoing injection site pain
Release 11 — day 0, dose 4
Systemic reaction (other): Weird taste back of tongue/throat
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Weird taste in back of mouth
Release 11 — day 21, dose 4
Symptoms: Slight/minor lingering pain and swelling at injection site.
Release 11 — day 42, dose 4
Symptoms: Very minor inspection site pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Dysgeusia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release